Back to Search
Start Over
Veracyte Announces Immunoscore Colon Cancer Test Included in ESMO1 Clinical Practice Guidelines Adapted for Pan-Asia
- Source :
- Plus Company Updates. November 6, 2021
- Publication Year :
- 2021
-
Abstract
- SOUTH SAN FRANCISCO, Calif.: Veracyte, Inc. (Nasdaq: VCYT) today announced that its Immunoscore Colon Cancer test has been included in the Pan-Asian adapted ESMO1 Clinical Practice Guidelines for the diagnosis, [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.681758209